Filing Details
- Accession Number:
- 0000908662-13-000062
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-30 16:35:58
- Reporting Period:
- 2013-01-29
- Filing Date:
- 2013-01-30
- Accepted Time:
- 2013-01-30 16:35:58
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1264587 | Stemline Therapeutics Inc | STML | Pharmaceutical Preparations (2834) | 450522567 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1209726 | Kevin J Buchi | C/O Stemline Therapeutics, Inc. 750 Lexington Avenue, 6Th Floor New York NY 10022 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-01-29 | 500 | $10.00 | 13,772 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- The shares were purchased in the Issuer's initial public offering.
Billionaire Hedge Funds
